Bioventus (BVS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.17
- Estimate
- $0.16
- Surprise
- +6.3%
- Revenue (period 2026-09-26)
- $142.4M
- Score at report (before → after)
- 5.8 → 5.7/10
Revenue source: xbrl.
How the report landed
Bioventus (BVS) beat the $0.16 estimate with adjusted EPS of $0.17 — a clear 6.3% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.8/10) to Hold at 5.7/10 after the report — the engine's score fell despite the beat.
Coverage in the report window
- Why Aehr Test Systems Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket — benzinga, 2026-11-03
Where TrendMatrix's rating stands now
TrendMatrix currently rates BVS Hold at 5.8/10.
3 of the last 4 quarters beat the estimate; this quarter's +6.3% surprise compares with a +34.6% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Weak growth
- Momentum score 4.1/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $13.15
- Price target
- $15.31
- Stop
- $12.23
- Upside to target
- +16.4%
- Reward-to-risk
- 1.8:1
The stock trades at 16.9× trailing but 14.3× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 1.6× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
BVS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $898.2M
- P/E (fwd)
- 14.3
- P/E (ttm)
- 16.9
- 52-week range
- $6.47–$15.89
- Off 52-week high
- 17.3%
- RSI (14)
- 46
- Volume vs avg
- 1.60×
- Score today
- 5.8/10